Showing results (2441-2450 of 6,777) with videos related to
Sort By:
Pageof 678
Clinical Therapeutics|January 1, 1996
The tolerability and safety profile of famotidineC W Howden, G N TytgatClinical Therapeutics|January 1, 1996
Erythromycin, clarithromycin, and azithromycin: are the differences real?G W AmsdenClinical Therapeutics|January 1, 1996
Inappropriate drug prescribing and related outcomes for elderly medicaid beneficiaries residing in nursing homesS Gupta, H M Rappaport, L T BennettClinical Therapeutics|March 2, 2006
Comparison of digitalis-related adverse events in hospitalized men and women in Italy: an observational studyClaudio Pedone, Andrea Corsonello, Luciana Carosella, et al.Clinical Therapeutics|March 2, 2006
Effects of switching from olanzapine to risperidone on the prevalence of the metabolic syndrome in overweight or obese patients with schizophrenia or schizoaffective disorder: analysis of a multicenter, rater-blinded, open-label studyJonathan M Meyer, Gahan Pandina, Cynthia A Bossie, et al.Clinical Therapeutics|March 2, 2006
A hospital perspective on the cost-effectiveness of beta-blockade for prophylaxis of atrial fibrillation after cardiothoracic surgeryEffie L Gillespie, C Michael White, Jeffrey Kluger, et al.Clinical Therapeutics|February 24, 2006
Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual functionMartin Miner, Matt T Rosenberg, Michael A PerelmanClinical Therapeutics|February 24, 2006
Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week studyRobert A Nathan, Anthony Rooklin, Lynne Schoaf, et al.Clinical Therapeutics|February 24, 2006
Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe painSharon M Weinstein, Minggao Shi, Barbara J Buckley, et al.Clinical Therapeutics|November 29, 2007
Abuse potential of carisoprodol: a retrospective review of Idaho Medicaid pharmacy and medical claims dataChristopher Owens, Brooke Pugmire, Ty Salness, et al.Pageof 678